Arthritis, Rheumatoid Clinical Trials

18 recruiting

Arthritis, Rheumatoid Trials at a Glance

18 actively recruiting trials for arthritis, rheumatoid are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Seoul, Duncansville, and Ann Arbor. Lead sponsors running arthritis, rheumatoid studies include AndHealth, Centre Hospitalier Régional d'Orléans, and Aalborg University Hospital.

Browse arthritis, rheumatoid trials by phase

Treatments under study

About Arthritis, Rheumatoid Clinical Trials

Looking for clinical trials for Arthritis, Rheumatoid? There are currently 18 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Arthritis, Rheumatoid trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Arthritis, Rheumatoid clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Phase 2

A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

Arthritis, Rheumatoid
Merck Sharp & Dohme LLC182 enrolled62 locationsNCT07176390
Recruiting
Not Applicable

Fucoidan in the Treatment of Active Rheumatoid Arthritis

Arthritis, Rheumatoid
Peking University People's Hospital40 enrolled1 locationNCT07045896
Recruiting

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

Arthritis, Rheumatoid
Eisai Korea Inc.2,040 enrolled64 locationsNCT06246123
Recruiting

Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

Arthritis, Rheumatoid
University of Michigan113 enrolled1 locationNCT00748254
Recruiting

Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases

Inflammatory Bowel DiseasesArthritis, RheumatoidSjogren's Syndrome+4 more
Centre Hospitalier Régional d'Orléans100 enrolled1 locationNCT06842316
Recruiting
Phase 4

Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study

Arthritis, Rheumatoid
Centre Hospitalier Universitaire de Saint Etienne180 enrolled8 locationsNCT06528431
Recruiting
Phase 1

R-2487 in Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid
Rise Therapeutics LLC73 enrolled5 locationsNCT05961592
Recruiting
Not Applicable

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

Arthritis, Rheumatoid
The Bionics Institute of Australia5 enrolled3 locationsNCT07017686
Recruiting
Not Applicable

Ultrasound to Guide Treatment Decisions in Patients With Rheumatoid Arthritis According to a T2T Approach

UltrasoundArthritis, RheumatoidTreat to Target
Italian Society for Rheumatology158 enrolled1 locationNCT05717179
Recruiting

Chronic Pain in Rheumatoid Arthritis

PainArthritis, Rheumatoid
Northwestern University125 enrolled5 locationsNCT05038553
Recruiting

Evolution and Treatments of Chronic Inflammatory Systemic Diseases

Inflammatory Bowel DiseasesCrohn DiseasePsoriasis+5 more
Centre Hospitalier Universitaire de Besancon3,000 enrolled1 locationNCT04191395
Recruiting
Not Applicable

Fecal Microbial Transplantation for Rheumatoid Arthritis Trial

ArthritisFecal Microbiota TransplantationArthritis, Rheumatoid
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's30 enrolled1 locationNCT05790356
Recruiting
Not Applicable

Impact of a High-fiber Diet on the Microbiome and Disease Activity in Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid
Wuerzburg University Hospital52 enrolled1 locationNCT06492200
Recruiting

Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.

Arthritis, RheumatoidArthritis, PsoriaticSpondylitis, Ankylosing
Aalborg University Hospital120 enrolled1 locationNCT04731831
Recruiting

IMPACT - AndHealth Autoimmune Research Registry

Ankylosing SpondylitisPsoriasisArthritis, Rheumatoid+2 more
AndHealth2,500 enrolled1 locationNCT05883371
Recruiting

Novel Complex Radiodiagnostics of Peripherial Arthropathies

Arthritis, RheumatoidArthritis, PsoriaticCrystal Arthropathies
Semmelweis University500 enrolled3 locationsNCT05657847
Recruiting
Phase 4

The Clinical Efficacy of Immunomodulators in RA Patients

Arthritis, Rheumatoid
Qilu Hospital of Shandong University400 enrolled1 locationNCT05626348
Recruiting

Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.

Arthritis, Rheumatoid
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla540 enrolled1 locationNCT05062421